Achieved durable production of serum AAT protein at levels associated with a lower risk of AATD liver and lung diseases following repeat 200 mg doses of WVE-006 (11.9 µM total AAT, 7.2 µM M-AAT) First ...

Detailed price information for Wave Life Sci Ord Sh (WVE-Q) from The Globe and Mail including charting and trades.

(MENAFN- GlobeNewsWire - Nasdaq) Achieved durable production of serum AAT protein at levels associated with a lower risk of AATD liver and lung diseases following repeat 200 mg doses of WVE-006 (11.9 ...

Wave Life Sciences (WVE) recently announced positive results from its Phase 1b/2a RestorAATion-2 study of WVE-006, showing favorable safety and promising clinical implications in treating alpha-1 ...

CAMBRIDGE, Mass., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to ...

Takeda offers a compelling investment case with six late-stage therapies targeting $20 billion in peak sales by 2030-31.

Prime Medicine has surged over 130% in three months, driven by pipeline progress and visibility from recent scientific ...

The American Red Cross held a blood drive at the Casco Community Center on Wednesday. Geoff Allen, who supervised the blood drive, said 20 people signed up and scheduled an appointment in advance and, ...

The latest update is out from Wave Life Sciences ( (WVE) ).

Beam Therapeutics Inc. (NASDAQ:BEAM) is one of the best emerging technology stocks to buy right now. The company develops ...